Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ferrando

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Minerva Anestesiologica|November 1, 1995
[Long term central venous catheterization revisited]S Palermo, A Campolucci, F Capozza, et al.
Acta Europaea Fertilitatis|May 1, 1993
The surgical correction of varicocele: multidisciplinary study on semen evaluation and prognostic factors for fertilityA F De Rose, S Scotto, G F Oppezzi, et al.
Actas Urologicas Espanolas|March 1, 1989
[Study of oligosaccharides in human urothelial membrane by means of lectins]F Ferrando, M C Sánchez, M Gil Salom, et al.
International Journal of Oncology|October 13, 2000
High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphomaA Ballestrero, M Clavio, F Ferrando, et al.
Oncology|July 15, 2000
Effects of three cytokine regimens on hematologic recovery and progenitor cell mobilization after high-dose cyclophosphamide, etoposide, and cisplatinA Ballestrero, F Ferrando, A Garuti, et al.
Journal of Thrombosis and Thrombolysis|July 4, 2019
Next generation sequencing in bleeding disorders: two novel variants in the F5 gene (Valencia-1 and Valencia-2) associated with mild factor V deficiencyA Moret, Ángel Zúñiga, M Ibáñez, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 10, 2001
Factor V Leiden and prothrombin G20210A in relation to arterial and/or vein rethrombosis: two casesY Mira, T Todolí, R Alonso, et al.
British Journal of Haematology|November 25, 2000
PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defectsR Seguí, A Estellés, Y Mira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Four-step high-dose sequential chemotherapy with double hematopoietic progenitor-cell rescue for metastatic breast cancerF Patrone, A Ballestrero, F Ferrando, et al.
Haematologica|December 13, 2000
Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptivesJ Aznar, A Vayá, A Estellés, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Minerva Anestesiologica|November 1, 1995
[Long term central venous catheterization revisited]S Palermo, A Campolucci, F Capozza, et al.
Acta Europaea Fertilitatis|May 1, 1993
The surgical correction of varicocele: multidisciplinary study on semen evaluation and prognostic factors for fertilityA F De Rose, S Scotto, G F Oppezzi, et al.
Actas Urologicas Espanolas|March 1, 1989
[Study of oligosaccharides in human urothelial membrane by means of lectins]F Ferrando, M C Sánchez, M Gil Salom, et al.
International Journal of Oncology|October 13, 2000
High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphomaA Ballestrero, M Clavio, F Ferrando, et al.
Oncology|July 15, 2000
Effects of three cytokine regimens on hematologic recovery and progenitor cell mobilization after high-dose cyclophosphamide, etoposide, and cisplatinA Ballestrero, F Ferrando, A Garuti, et al.
Journal of Thrombosis and Thrombolysis|July 4, 2019
Next generation sequencing in bleeding disorders: two novel variants in the F5 gene (Valencia-1 and Valencia-2) associated with mild factor V deficiencyA Moret, Ángel Zúñiga, M Ibáñez, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 10, 2001
Factor V Leiden and prothrombin G20210A in relation to arterial and/or vein rethrombosis: two casesY Mira, T Todolí, R Alonso, et al.
British Journal of Haematology|November 25, 2000
PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defectsR Seguí, A Estellés, Y Mira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Four-step high-dose sequential chemotherapy with double hematopoietic progenitor-cell rescue for metastatic breast cancerF Patrone, A Ballestrero, F Ferrando, et al.
Haematologica|December 13, 2000
Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptivesJ Aznar, A Vayá, A Estellés, et al.
Pageof 5